Zepp Health Co. (NYSE:ZEPP) Short Interest Update

Zepp Health Co. (NYSE:ZEPP - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 52,900 shares, a growth of 2,304.5% from the March 15th total of 2,200 shares. Currently, 0.2% of the company's stock are sold short. Based on an average trading volume of 73,600 shares, the days-to-cover ratio is presently 0.7 days.

Analysts Set New Price Targets

Separately, Fundamental Research set a $4.96 target price on Zepp Health and gave the stock a "buy" rating in a research report on Tuesday, March 26th.

Institutional Investors Weigh In On Zepp Health

A number of institutional investors have recently made changes to their positions in ZEPP. Envestnet Asset Management Inc. bought a new position in Zepp Health during the first quarter worth about $49,000. BlackRock Inc. increased its stake in Zepp Health by 1.2% in the 1st quarter. BlackRock Inc. now owns 612,416 shares of the company's stock valued at $1,764,000 after buying an additional 7,427 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Zepp Health by 25.0% during the first quarter. Dimensional Fund Advisors LP now owns 189,774 shares of the company's stock worth $547,000 after acquiring an additional 37,952 shares in the last quarter. Renaissance Technologies LLC acquired a new position in Zepp Health during the first quarter valued at approximately $107,000. Finally, Invesco Ltd. grew its stake in Zepp Health by 58.9% in the first quarter. Invesco Ltd. now owns 43,383 shares of the company's stock valued at $125,000 after purchasing an additional 16,087 shares in the last quarter. 52.61% of the stock is owned by institutional investors and hedge funds.

Zepp Health Stock Performance

ZEPP stock traded down $0.04 during midday trading on Wednesday, hitting $0.91. The stock had a trading volume of 56,277 shares, compared to its average volume of 71,553. The stock has a 50-day simple moving average of $1.14 and a 200 day simple moving average of $1.25. The firm has a market capitalization of $55.81 million, a price-to-earnings ratio of -1.86 and a beta of 0.81. Zepp Health has a 52 week low of $0.90 and a 52 week high of $2.10. The company has a current ratio of 2.04, a quick ratio of 1.49 and a debt-to-equity ratio of 0.34.

Zepp Health (NYSE:ZEPP - Get Free Report) last announced its earnings results on Monday, March 18th. The company reported ($0.02) EPS for the quarter. Zepp Health had a negative return on equity of 8.55% and a negative net margin of 8.66%. The business had revenue of $84.47 million during the quarter.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.